The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.00
Ask: 138.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.73%)
Open: 138.00
High: 138.00
Low: 137.50
Prev. Close: 137.50
SUP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Nomad and Joint Brokers

23 Oct 2023 07:00

RNS Number : 8832Q
Supreme PLC
23 October 2023
 

23 October 2023

 

Supreme plc

("Supreme," the "Company" or the "Group")

 

Appointment of Nomad and Joint Brokers

and

AIM Rule 17 Disclosures

 

 

Supreme (AIM: SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, is pleased to announce the appointment of Shore Capital and Corporate Limited as Nominated Adviser and Shore Capital Stockbrokers Limited and Zeus Capital Limited as Joint Brokers to the Company with immediate effect.

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Shore Capital (Nominated Adviser and Joint Broker)

Mark Percy - Corporate Advisory

David Coaten

Rachel Goldstein 

Ben Canning - Corporate Broking

 

+44 (0)20 7408 4090

Zeus (Joint Broker)

Jordan Warburton / Alex Campbell-Harris - Investment Banking

Benjamin Robertson - Corporate Broking

 

+44 (0)161 831 1512

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites.

 

investors.supreme.co.uk/

 

AIM Rule 17 Disclosures

The Company announces that the following information is being disclosed pursuant to Rule 17 and Schedule Two, Paragraph (g) of the AIM Rules for Companies as an update to the information provided in the Company's AIM admission document published on 27 January 2021.

 

Sandy Chadha - Chief Executive Officer

At the time of publication of the Admission Document, Sandy was a director of the following companies:

· GT Divisions Limited

· Holding Esser Affairs B.V.

 

Suzanne Smith - Chief Finance Officer

At the time of publication of the Admission Document, Suzanne was a director of the following Company:

· Supreme Nominees Limited

 

Simon Lord - Non-Executive Director

At the time of publication of the Admission Document, Simon was a director at the following Companies:

· Arete Asset Management Limited

· Arete Holdings Limited

· Arete Wealth Management Limited

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPEAPEAAAEDFFA
12
Date   Source Headline
24th Apr 20247:00 amRNSYear End Trading Update
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20247:00 amRNSCommencement of Share Buyback Programme
29th Jan 20242:42 pmRNSMarket and Trading Update and Share Buyback
5th Jan 20247:00 amRNSAcquisition of protein manufacturing assets
2nd Jan 20247:00 amRNSBlock Admission Return
29th Dec 20237:00 amRNSTotal Voting Rights
1st Dec 20238:58 amRNSGrant of Options and Director Dealing
28th Nov 20237:00 amRNSHalf-year Results
31st Oct 20237:00 amRNSTotal Voting Rights
23rd Oct 20237:00 amRNSAppointment of Nomad and Joint Brokers
18th Oct 20237:01 amRNSVaping Category Update
18th Oct 20237:00 amRNSTrading Statement & Notice of Results
4th Oct 202310:50 amRNSDirector Share Purchase
26th Sep 202312:07 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Trading Statement
13th Sep 20238:31 amRNSResponse to Media Speculation
23rd Aug 20237:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 20237:01 amRNSSignificant Vaping Distribution Appointment
5th Jul 20237:00 amRNSFinal Results
3rd Jul 20237:00 amRNSBlock Admission of Shares
19th Jun 20239:30 amRNSNotice of Results & Investor Presentation
15th May 20233:07 pmRNSDirector Share Purchase
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 202311:56 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSYear End Trading Update
31st Mar 20237:00 amRNSTotal Voting Rights
14th Mar 20232:30 pmRNSDisposal of the IP of T-Juice
28th Feb 202312:34 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSBlock Admission of Shares
13th Jan 20237:00 amRNSHolding(s) in Company
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSStrong Q3 Trading
29th Nov 20227:00 amRNSHalf-year Results
24th Oct 20227:00 amRNSTrading Update and Notice of Results
15th Sep 20225:08 pmRNSResult of AGM
15th Sep 20227:00 amRNSAGM Statement
22nd Aug 202211:06 amRNSSecond Price Monitoring Extn
22nd Aug 202211:00 amRNSPrice Monitoring Extension
15th Aug 20227:00 amRNSAvailability of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSAcquisition of Cuts Ice/Flavour Core trade/assets
8th Aug 20227:00 amRNSGrant of performance share awards to a PDMR
25th Jul 20227:00 amRNSDirector Share Purchase
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.